The Fourth Wave: Fentanyl and the Overdose Crisis
The Fourth Wave: Fentanyl and the Overdose Crisis
Sponsored by: California Department of Health Care Services (CA DHCS), Opioid and Stimulant Implementation Support-Training and Technical Assistance (OASIS-TTA)-MAT Expansion Project, UCLA Integrated Substance Abuse Programs (UCLA ISAP), Pacific Southwest Addiction Technology Transfer Center (PSATTC), HHS Region 9, & Opioid Response Network STR-TA
Course Description
This on-demand course will address “The Fourth Wave” of the opioid epidemic, including recent data on rising mortality due to fentanyl alone and in combination with methamphetamine. The rise of polysubstance use, including the use of the so called “goofball,” has implications for morbidity and mortality and raises the complexity of treatment. Treatment options, including use of medications, will be discussed. The session will also cover harm reduction strategies including naloxone, drug surveillance, and drug checking. This session will also include training on how to use fentanyl test strips, as part of a comprehensive public health and harm reduction strategy. Fentanyl test strips are a practical and effective tool for people who use drugs as means to encourage overdose risk education and reduce risk of death. Training will include discussion on distribution, limitations, sourcing, messaging amongst other considerations in the application and administration of use.
Launch Date: November 12, 2021
At the conclusion of the training, participants will be able to:
1. Recall the history, epidemiology and use patterns of two (2) drug classes, including synthetic opioids and stimulants.
2. Explain two (2) poly-drug use patterns involving synthetic opioids and methamphetamines and develop treatment strategies.
3. Propose three (3) harm reduction measures to prevent overdose deaths due to synthetic opioids.
4. Identify two (2) steps required when testing drug supply using Fentanyl Test Strips.
Instructions for Continuing Education Credits
How to receive a CE/CME certificate:
For Continuing Medical Education (CME) for physicians, physician assistants, nurses, and nurse practitioners only, you will receive a link to complete the course evaluation for CME after watching the video for this course, and you will receive your CE certificate via email within six to eight weeks.
If you have any CME-related questions, please contact Gloria Miele at gmiele@mednet.ucla.edu.
For other disciplines, you must pass the final test with a minimum of 80% correct. Once you pass the final test, you will be given links to complete a follow-up course evaluation. Choose the link that corresponds with the type of license you have. The link will take you to a course evaluation. Once you submit this required course evaluation, you will receive your CE certificate via email within six to eight weeks.
If you have any CE-related questions, please contact Darren Manley at dmanley@mednet.ucla.edu.
CME Statements:
Please view the linked CME Learner Handout for more information about how to obtain CME credit.
The training course meets the qualifications for the provision of two (2.0) continuing medical education credits/contact hours (CMEs/CEHs).
UCLA Integrated Substance Abuse Programs (ISAP) is accredited by the California Medical Association (CMA) to provide continuing medical education for physicians.
UCLA ISAP CME designates this online activity for a maximum of 2.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The California Board of Registered Nursing recognizes that Continuing Medical Education (CME) is acceptable for meeting RN continuing education requirements as long as the course is certified for AMA PRA Category 1 CreditsTM (rn.ca.gov). Nurses will receive a Certificate of Participation following this activity that may be used for license renewal.
Continuing medical education credit will be awarded within 6-8 weeks following completion of the web training.
Continuing Education:
The training course meets the qualifications for the provision of two (2.0) continuing education credits/contact hours (CEs/CEHs). UCLA Integrated Substance Abuse Programs (ISAP) is approved by the American Psychological Association to sponsor continuing education for psychologists. UCLA ISAP maintains responsibility for this program and its content
UCLA ISAP is approved by the California Association of Marriage and Family Therapists to sponsor continuing education for LMFTs, LCSWs, LPCCs, and/or LEPs (Provider #64812). UCLA ISAP maintains responsibility for this program/course and its content. Course meets the qualifications for two (2.0) hours of continuing education credit for LMFTs, LCSWs, LPCCs, and LEPs as required by the California Board of Behavioral Sciences. UCLA ISAP is also an approved provider of continuing education for RADTs I/II, CADCs-CASs, CADCs I/II, CADCs-CSs, and LAADCs (CCAPP, #2N-21-339-1225), CATCs (ACCBC/CAADE, #CP40 872 C 0825), and CAODCs (CADTP, #151).
CE credit will be awarded at the conclusion of the training. Upon completing the final module, you must pass the final test with a minimum of 80% correct. Once you pass the final test, it will display a link to complete a course evaluation and submit the required information for your CE certificate. Upon completing this required course evaluation, you will receive your CE certificate via email within six to eight weeks.
If you have any CE-related questions, please contact Darren Manley at dmanley@mednet.ucla.edu.
Estimated time to complete the course:
Cost: Free
Disclosure statements:
Dan Ciccarone, MD, MPH – University of California, San Francisco
DISCLOSURES: Dr. Ciccarone is on the Scientific Advisory Board of Celero Systems and an expert witness in federal opioid litigation for Motley Rice LLC. All of the relevant financial relationships listed have been mitigated.
Amanda Cowan, MS – CLARE|MATRIX
None of the other presenters, planners, or others in control of content for this educational activity have relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Trainers:
Dan Ciccarone, MD, MPH – University of California, San Francisco
Amanda Cowan, MS – CLARE|MATRIX
Recommended Audience:
This on-demand course is recommended for medical, behavioral health, and substance use disorder clinicians and administrative staff who are involved in providing multidisciplinary care to persons with opioid, stimulant, and other substance use disorders, including, but not limited to:
- Physicians
- Physician Assistants
- Nurse Practitioners
- Registered Nurses and LVNs
- Psychologists
- Marriage and Family Therapists
- Social Workers
- Alcohol and Other Drug and Mental Health Counselors
- Case Managers
- Medical Assistants
Instructions for Requesting Accommodations for Disability:
If you need a disability-related reasonable accommodation/alternative format for this event, please contact Darren Manley at dmanley@mednet.ucla.edu.
Instructions for Filing a Grievance Concerning UCLA ISAP’s Continuing Education Program:
Please contact Dr. Thomas E. Freese, CE Program Administrator, in writing (UCLA ISAP, 10911 Weyburn Avenue, Suite 200, Los Angeles, CA 90024-2886) or by phone (310-267-5397). Alternately, you may contact Dr. Gloria Miele or Dr. James Peck, ISAP-affiliated doctoral-level psychologists responsible for program planning for the ISAP CE Program. Drs. Miele and Peck can be reached in writing at: 10911 Weyburn Avenue, Suite 200, Los Angeles, CA 90024-2886 or by phone at: 310-267-5888 (Miele) or 310-267-5346 (Peck).
